These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Principles of controlled trials (author's transl)]. Fink H Arzneimittelforschung; 1978; 28(11a):2017-9. PubMed ID: 383091 [TBL] [Abstract][Full Text] [Related]
3. [Problem of the evaluation of experimental research for clinical testing of new drugs in man]. Kleinsorge H Arzneimittelforschung; 1975 Jul; 25(7a):1112-20. PubMed ID: 1242338 [TBL] [Abstract][Full Text] [Related]
4. [Experimental design in phase I (AUTHOR'S TRANSL)]. Uberla K Arzneimittelforschung; 1978; 28(11a):2032-6. PubMed ID: 383093 [TBL] [Abstract][Full Text] [Related]
5. Alternative strategies in drug development: clinical pharmacological aspects. Kuhlmann J Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949 [TBL] [Abstract][Full Text] [Related]
6. Asymptotic behaviour of open compartmented systems with applications to pharmacology. Turinici M; Rusu V; Baran T Rev Med Chir Soc Med Nat Iasi; 1979; 83(1):105-9. PubMed ID: 545570 [No Abstract] [Full Text] [Related]
8. [Administrative and juridicial problems in psychopharmacology (author's transl)]. Heimann H Arzneimittelforschung; 1975 Nov; 25(11):1809-13. PubMed ID: 1106443 [TBL] [Abstract][Full Text] [Related]
9. Potential roles for preclinical pharmacology in phase I clinical trials. Collins JM; Zaharko DS; Dedrick RL; Chabner BA Cancer Treat Rep; 1986 Jan; 70(1):73-80. PubMed ID: 3753662 [TBL] [Abstract][Full Text] [Related]
10. [Critical survey on liver microsome test, a system for detecting point mutations (author's transl)]. Herbold B; Buselmaier W; Röhrborn G Arzneimittelforschung; 1976; 26(9):1705-7. PubMed ID: 1036705 [TBL] [Abstract][Full Text] [Related]
11. [Relationship between basic and clinical pharmacology (author's transl)]. Lecannelier S Rev Med Chil; 1978 Mar; 106(3):163-4. PubMed ID: 663452 [No Abstract] [Full Text] [Related]
12. [Responsibilities of clinical pharmacology in the early phase of drug development]. Kuhlmann J Med Klin (Munich); 2000 May; 95(1 Spec No):31-40. PubMed ID: 10851846 [TBL] [Abstract][Full Text] [Related]
13. [Problems in dose finding from the view of the clinical pharmacologist (author's transl)]. Weber E Arzneimittelforschung; 1977 Feb; 27(2A):264-72. PubMed ID: 577173 [TBL] [Abstract][Full Text] [Related]
14. Relation of preclinical toxicology to findings in early clinical trials. Grieshaber CK; Marsoni S Cancer Treat Rep; 1986 Jan; 70(1):65-72. PubMed ID: 3943115 [TBL] [Abstract][Full Text] [Related]
15. [MASCA-model of the biochemical-pharmacological drug research. Part 2: Multivariate test criterions and methods (author's transl)]. Mager PP Arzneimittelforschung; 1975 Aug; 25(8):1270-2. PubMed ID: 1242357 [No Abstract] [Full Text] [Related]
16. [Depot neuroleptics - practical method of the longtime treatment and methodological problems of clinical trials (author's transl)]. Woggon B Ther Umsch; 1975 Aug; 32(8):501-6. PubMed ID: 1162636 [No Abstract] [Full Text] [Related]
17. [Clinico-chemical methods within a drug monitoring system in psychiatry (author's transl)]. Müller-Oerlinghausen B Arzneimittelforschung; 1980; 30(8):1176-7. PubMed ID: 7192128 [TBL] [Abstract][Full Text] [Related]
18. [Bioavailability, proof of efficacy and their consequences for drug legislation (author's transl)]. Schnieders B Arzneimittelforschung; 1976; 26(1A):158-63. PubMed ID: 947195 [TBL] [Abstract][Full Text] [Related]
19. [On evaluation of new drug--case of clomipramine (Anafranil)--(author's transl)]. Tsukasaki N Seishin Shinkeigaku Zasshi; 1975 Oct; 77(10):737-44. PubMed ID: 1243688 [No Abstract] [Full Text] [Related]
20. [Biophysical aspects of the functional diagnosis of the localization and nature of drug action]. Dmitrieva NV Izv Akad Nauk SSSR Biol; 1982; (1):85-91. PubMed ID: 7061761 [No Abstract] [Full Text] [Related] [Next] [New Search]